AYTU BIOPHARMA, INC Payments of Debt Issuance Costs
AYTU BIOPHARMA, INC (AYTU) reported Payments of Debt Issuance Costs of $0 for the 12-month period ending 2026-06-30, per its 10-K filed 2026-09-22.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsOfDebtIssuanceCosts · last filed 2026-09-22
- AYTU BIOPHARMA, INC payments of debt issuance costs for the quarter ending 2024-06-30 was $273.00K.
- AYTU BIOPHARMA, INC payments of debt issuance costs for the quarter ending 2023-06-30 was $0.00, a 100.00% decline year-over-year.
- AYTU BIOPHARMA, INC payments of debt issuance costs for the quarter ending 2022-06-30 was $163.00K.
- AYTU BIOPHARMA, INC payments of debt issuance costs for the quarter ending 2017-06-30 was $0.00.
- AYTU BIOPHARMA, INC payments of debt issuance costs for fiscal 2026 was $0.00, a 100.00% decline from fiscal 2025.
- AYTU BIOPHARMA, INC payments of debt issuance costs for fiscal 2025 was $49.00K, a 82.05% decline from fiscal 2024.
- AYTU BIOPHARMA, INC payments of debt issuance costs for fiscal 2024 was $273.00K, a 196.74% increase from fiscal 2023.
- AYTU BIOPHARMA, INC payments of debt issuance costs for fiscal 2023 was $92.00K, a 82.51% decline from fiscal 2022.
| Period end | Payments of Debt Issuance Costs 3 month | Payments of Debt Issuance Costs 6 month | Payments of Debt Issuance Costs 9 month | Payments of Debt Issuance Costs 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 10-K · filed 2026-09-22 | |||
| 2025-06-30 | $49.00K 10-K · filed 2026-09-22 | |||
| 2024-06-30 | $273.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-23 | $273.00K 10-K · filed 2025-09-23 | ||
| 2024-03-31 | $0.00 10-Q · filed 2024-05-15 | |||
| 2023-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-09-26 | $92.00K 10-K · filed 2024-09-26 | ||
| 2023-03-31 | $92.00K 10-Q · filed 2024-05-15 | |||
| 2022-06-30 | $163.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-10-12 | $526.00K 10-K · filed 2023-10-12 | ||
| 2022-03-31 | $363.00K 10-Q · filed 2023-05-11 | |||
| 2021-06-30 | $0.00 10-K · filed 2022-09-27 | |||
| 2017-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-08-31 | $0.00 derived: sum of 2 quarters · filed 2017-08-31 | $0.00 derived: sum of 3 quarters · filed 2017-08-31 | $0.00 10-K · filed 2017-08-31 |
| 2017-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-05-11 | $0.00 derived: sum of 2 quarters · filed 2017-05-11 | $0.00 10-Q · filed 2017-05-11 | $0.00 derived: sum of 4 quarters · filed 2017-08-31 |
| 2016-12-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-02-09 | $0.00 10-Q · filed 2017-02-09 | $0.00 derived: sum of 3 quarters · filed 2017-08-31 | $0.00 derived: sum of 4 quarters · filed 2017-08-31 |
| 2016-09-30 | $0.00 10-Q · filed 2016-11-07 | $0.00 derived: sum of 2 quarters · filed 2017-08-31 | $0.00 derived: sum of 3 quarters · filed 2017-08-31 | $0.00 derived: sum of 4 quarters · filed 2017-08-31 |
| 2016-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-08-31 | $0.00 derived: sum of 2 quarters · filed 2017-08-31 | $0.00 derived: sum of 3 quarters · filed 2017-08-31 | $298.32K 10-K · filed 2017-08-31 |
| 2016-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-05-11 | $0.00 derived: sum of 2 quarters · filed 2017-05-11 | $298.32K 10-Q · filed 2017-05-11 | $298.32K derived: sum of 4 quarters · filed 2017-05-11 |
| 2015-12-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-02-09 | $298.32K 10-Q · filed 2017-02-09 | $298.32K derived: sum of 3 quarters · filed 2017-02-09 | |
| 2015-09-30 | $298.32K 10-Q · filed 2016-11-07 | $298.32K derived: sum of 2 quarters · filed 2016-11-07 | ||
| 2015-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-09-01 | $0.00 10-K · filed 2016-09-01 | ||
| 2015-03-31 | $0.00 10-Q · filed 2016-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |